Private-equity firm Veritas Capital and hedge fund Elliott Management are buying Athenahealth for about US$5.7 billion, the US health-care software maker announced on Monday, November 12.
Athenahealth had been under pressure from Elliott to sell itself since the hedge fund acquired a stake in the company last year. In May, Elliott made an unsolicited offer of US$160 per share to buy Athenahealth. Reuters reported on Sunday that Athenahealth had agreed to a takeover.
Once the deal is complete, Athenahealth will merge with Virence Health, the former GE Healthcare unit that Veritas acquired earlier this year, the companies announced in a joint statement.
A deal for Athenahealth represents the largest deal to date for Elliott’s private-equity arm, Evergreen.
Featured News
Italy’s Antitrust Regulator Investigates State Railway Operators for Market Abuse
Mar 23, 2025 by
CPI
Democrats Urge Trump to Reinstate Ousted FTC Commissioners
Mar 23, 2025 by
CPI
White House-Led Talks Focus on U.S. Investor Takeover of TikTok
Mar 23, 2025 by
CPI
Oregon Lawmakers Target Algorithmic Price-Fixing in Rental Market
Mar 23, 2025 by
CPI
New Merger Disclosure Rules Double Review Time, Complicate Deal Process
Mar 23, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Self-Preferencing
Feb 26, 2025 by
CPI
Platform Self-Preferencing: Focusing the Policy Debate
Feb 26, 2025 by
Michael Katz
Weaponized Opacity: Self-Preferencing in Digital Audience Measurement
Feb 26, 2025 by
Thomas Hoppner & Philipp Westerhoff
Self-Preferencing: An Economic Literature-Based Assessment Advocating a Case-By-Case Approach and Compliance Requirements
Feb 26, 2025 by
Patrice Bougette & Frederic Marty
Self-Preferencing in Adjacent Markets
Feb 26, 2025 by
Muxin Li